Ameritas Investment Partners’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,255
Closed -$528K 3158
2023
Q1
$528K Buy
2,255
+42
+2% +$10.6K 0.02% 748
2022
Q4
$557K Hold
2,213
0.02% 749
2022
Q3
$392K Buy
2,213
+173
+8% +$34.8K 0.02% 818
2022
Q2
$372K Sell
2,040
-62
-3% -$12.4K 0.02% 833
2022
Q1
$540K Hold
2,102
0.02% 782
2021
Q4
$484K Hold
2,102
0.02% 820
2021
Q3
$490K Sell
2,102
-27
-1% -$5.63K 0.02% 801
2021
Q2
$411K Hold
2,129
0.01% 846
2021
Q1
$441K Sell
2,129
-102
-5% -$21.7K 0.02% 822
2020
Q4
$420K Hold
2,231
0.02% 814
2020
Q3
$288K Sell
2,231
-81
-4% -$8.93K 0.01% 880
2020
Q2
$201K Buy
2,312
+1,093
+90% +$84K 0.01% 1020
2020
Q1
$73K Hold
1,219
﹤0.01% 1442
2019
Q4
$90K Hold
1,219
﹤0.01% 1573
2019
Q3
$74K Hold
1,219
﹤0.01% 1648
2019
Q2
$74K Hold
1,219
﹤0.01% 1687
2019
Q1
$69K Buy
1,219
+608
+100% +$32.9K ﹤0.01% 1700
2018
Q4
$26K Hold
611
﹤0.01% 2185
2018
Q3
$26K Hold
611
﹤0.01% 2377
2018
Q2
$22K Buy
+611
New +$19.7K ﹤0.01% 2460

Other funds holding INSP

Ameritas Investment Partners's INSP Position: Q2 2023 in Review

Ameritas Investment Partners sold out of Inspire Medical Systems (INSP) in Q2 2023, closing a stake of 2,255 shares — an estimated $528K sold.

Ameritas Investment Partners first reported a position in INSP in Q2 2018 and held it in 20 quarters. The position peaked at $557K in Q4 2022. 407 funds tracked by Wall St. Rank hold INSP as of Q2 2023.

  • Ameritas Investment Partners reported no remaining Inspire Medical Systems position as of Q2 2023 after selling out during the quarter.
  • Ameritas Investment Partners sold 2,255 Inspire Medical Systems shares in Q2 2023, an estimated $528K.
  • Ameritas Investment Partners first reported a position in Inspire Medical Systems in Q2 2018 and held it in 20 quarters.
  • Ameritas Investment Partners's Inspire Medical Systems position peaked at $557K in Q4 2022.
  • 407 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2023.

Based on Ameritas Investment Partners's 13F filing for Q2 2023, filed 11 Aug 2023.